Kynurenines in the CNS: recent advances and new questions - PubMed (original) (raw)

Review

doi: 10.1038/nrd3793. Epub 2012 Dec 14.

Affiliations

Review

Kynurenines in the CNS: recent advances and new questions

László Vécsei et al. Nat Rev Drug Discov. 2013 Jan.

Abstract

Various pathologies of the central nervous system (CNS) are accompanied by alterations in tryptophan metabolism. The main metabolic route of tryptophan degradation is the kynurenine pathway; its metabolites are responsible for a broad spectrum of effects, including the endogenous regulation of neuronal excitability and the initiation of immune tolerance. This Review highlights the involvement of the kynurenine system in the pathology of neurodegenerative disorders, pain syndromes and autoimmune diseases through a detailed discussion of its potential implications in Huntington's disease, migraine and multiple sclerosis. The most effective preclinical drug candidates are discussed and attention is paid to currently under-investigated roles of the kynurenine pathway in the CNS, where modulation of kynurenine metabolism might be of therapeutic value.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Nat Neurosci. 2002 May;5(5):405-14 - PubMed
    1. Eur J Pharmacol. 2000 Mar 3;390(3):267-74 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 2011 May;383(5):447-55 - PubMed
    1. Neuroscience. 1997 Jun;78(4):967-75 - PubMed
    1. J Immunol. 2006 Jul 1;177(1):130-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources